Tekla Capital Management LLC - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 43 filers reported holding VYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$20,309
-32.3%
135,3950.0%0.00%0.0%
Q3 2022$30,000
-43.4%
135,3950.0%0.00%
-50.0%
Q2 2022$53,000
-39.8%
135,3950.0%0.00%
-33.3%
Q1 2022$88,000
-36.2%
135,3950.0%0.00%
-25.0%
Q4 2021$138,000
-26.6%
135,3950.0%0.00%
-33.3%
Q3 2021$188,000
-60.4%
135,3950.0%0.01%
-60.0%
Q2 2021$475,000
-48.8%
135,3950.0%0.02%
-53.1%
Q1 2021$927,000135,3950.03%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders